Hetti Handi Chaminda Lakmal

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation”.

Improvement of the Metabolic Stability of GPR88 Agonist RTI-13951-33: Design, Synthesis, and Biological Evaluation

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.2c01983

N/A

0DataRank · unranked

14 citations

Ann M. Decker, Sami Ben Hamida, David A. Perrey, Hetti Handi Chaminda Lakmal, Rangan Maitra +4 more

Design, Synthesis, and Structure–Activity Relationship Studies of Novel GPR88 Agonists (4-Substituted-phenyl)acetamides Based on the Reversed Amide Scaffold

ACS Chemical Neuroscience(2023)10.1021/acschemneuro.3c00684

N/A

0DataRank · unranked

6 citations

Dongliang Guan, Hetti Handi Chaminda Lakmal, Ann M. Decker, Gregory H. Imler, Andrew T. Kerr +3 more

Targeting the relaxin-3/RXFP3 system: a patent review for the last two decades

Expert Opinion on Therapeutic Patents(2024)10.1080/13543776.2024.2338099

N/A

0DataRank · unranked

3 citations

Hetti Handi Chaminda Lakmal, Javeena Hussain, Chunyang Jin, Md Toufiqur Rahman

Development of Diphenyl-1,2,4-Oxadiazole Analogues as Allosteric Modulators of the RXFP3 Receptor: Evaluation of Importance of the N-Substituted-2-Pyrrolidone Moiety in RLX-33

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00361

N/A

0DataRank · unranked

2 citations

Hetti Handi Chaminda Lakmal, Brooke N. Bender, Md Toufiqur Rahman, Elaine A. Gay, Daniel G. Barrus +5 more